NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,436 | -58.7% | 4,146 | 0.0% | 0.00% | – |
| Q2 2023 | $10,738 | -70.6% | 4,146 | -53.7% | 0.00% | -100.0% |
| Q1 2023 | $36,569 | -18.7% | 8,963 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $44,994 | -57.1% | 8,963 | +11.9% | 0.00% | -50.0% |
| Q3 2022 | $105,000 | +69.4% | 8,012 | +66.3% | 0.00% | +100.0% |
| Q2 2022 | $62,000 | +100.0% | 4,817 | +138.8% | 0.00% | – |
| Q1 2022 | $31,000 | -26.2% | 2,017 | +0.8% | 0.00% | -100.0% |
| Q3 2021 | $42,000 | +7.7% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | -100.0% | 2,000 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $116,280,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |